Composition comprising VLP and amyloid-beta peptide

Details for Australian Patent Application No. 2011253800 (hide)

Owner Novartis AG

Inventors Blattler, Thomas; Graf, Ana; Paganetti, Paolo; Staufenbiel, Matthias

Agent Davies Collison Cave

Pub. Number AU-A-2011253800

Parent 2010200410

Filing date 2 December 2011

Wipo publication date 12 January 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 December 2011 Complete Application Filed

12 January 2012 Application Open to Public Inspection

  Published as AU-A-2011253800

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011253801-Mobile Base

2011253799-Columnar air moving devices, systems and methods